Search

Search results

173 results found

Kathryn M. Hatch, MD, named "Outstanding female leader in ophthalmology"

MillennialEYE named Kathryn M. Hatch, MD, an “Outstanding female leader in ophthalmology” in their January/February 2017, and published a profile about her career and work. MillennialEYE is an all-digital publication and online community for the future leaders in ophthalmology. The full story can be...

A pocket-sized retina camera, no dilating required

Boston, Mass. — It’s the part of the eye exam everyone hates: the pupil-dilating eye drops. The drops work by opening the pupil and preventing the iris from constricting in response to light and are often used for routine examination and photography of the back of the eye. The drops sting, can take...

2017-2018 Heed Fellows

Five Ophthalmology residents have been selected for 2017-2018 Heed fellowships by the Heed Ophthalmic Foundation and the Society of Heed Fellows . This accounts for nearly 25% of of all awarded Heed fellowships this year. Congratulations to: Durga Borkar, MD Eric Gaier, MD, PhD James (Tony) Stefater...

Joan Miller, MD, appointed to AUPO Board of Trustees

Joan W. Miller, MD, has been appointed to the Association of University Professors of Ophthalmology (AUPO) Board of Trustees. As Chair of Harvard Ophthalmology since 2003, Dr. Miller is committed driving innovation and quality in academic medicine, and strongly supports mentoring and developing...

Michael Gilmore, PhD, chairs $20 million antibiotic-resistance challenge

In March 2017, Michael Gilmore, PhD, Director of the Harvard Infectious Disease Institute, chaired a blue ribbon panel that reviewed the most promising applications for the Antimicrobial Resistance Diagnostic Challenge--a $20 million federal prize competition to develop innovative, rapid point-of...

Systemic therapy outperforms intraocular implant for treating uveitis

After seven years, multi-center clinical trial finds systemic therapy better preserves visual acuity and has fewer side effects Boston, Mass. — Systemic therapy consisting of corticosteroids and immunosuppressants preserved vision of uveitis patients better – and had fewer adverse outcomes – than a...

Eli Peli joins Board of Directors for non-profit ride service

Eli Peli, MSc, OD, has joined the board for directors of ITN America. This non-profit provides ride services for the elderly and visually impaired. They support sustainable, community-based transportation services for seniors throughout the world by building a senior transportation network through...